Author: admin

SAN FRANCISCO and SUZHOU, China, Feb. 16, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascula

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: